CN111107858A - 性功能障碍的治疗和性生活质量的改善 - Google Patents

性功能障碍的治疗和性生活质量的改善 Download PDF

Info

Publication number
CN111107858A
CN111107858A CN201880046823.4A CN201880046823A CN111107858A CN 111107858 A CN111107858 A CN 111107858A CN 201880046823 A CN201880046823 A CN 201880046823A CN 111107858 A CN111107858 A CN 111107858A
Authority
CN
China
Prior art keywords
stem cells
mesenchymal stem
sexual
patient
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880046823.4A
Other languages
English (en)
Chinese (zh)
Inventor
D·L·迪非德
约书亚·M·哈尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Life Science Co
Original Assignee
American Life Science Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Life Science Co filed Critical American Life Science Co
Publication of CN111107858A publication Critical patent/CN111107858A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201880046823.4A 2017-06-19 2018-06-15 性功能障碍的治疗和性生活质量的改善 Pending CN111107858A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762521765P 2017-06-19 2017-06-19
US62/521,765 2017-06-19
PCT/US2018/037725 WO2018236680A1 (en) 2017-06-19 2018-06-15 TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT OF THE QUALITY OF SEXUAL LIFE

Publications (1)

Publication Number Publication Date
CN111107858A true CN111107858A (zh) 2020-05-05

Family

ID=62952383

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880046823.4A Pending CN111107858A (zh) 2017-06-19 2018-06-15 性功能障碍的治疗和性生活质量的改善

Country Status (12)

Country Link
US (1) US12496316B2 (enExample)
EP (1) EP3641793A1 (enExample)
JP (1) JP7343123B2 (enExample)
KR (1) KR20200017516A (enExample)
CN (1) CN111107858A (enExample)
AU (1) AU2018288653A1 (enExample)
CA (1) CA3067354A1 (enExample)
IL (1) IL271395A (enExample)
SG (1) SG11201912209UA (enExample)
TW (1) TW201919664A (enExample)
WO (1) WO2018236680A1 (enExample)
ZA (1) ZA201908451B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021340971A1 (en) 2020-09-08 2023-03-30 Longeveron, Inc. Treatment of Alzheimer's disease with allogeneic mesenchymal stem cells
EP4376950A1 (en) 2021-07-26 2024-06-05 Longeveron Inc. Use of mesenchymal stem cells in treatment of juvenile hypoplastic left heart syndrome
CA3226181A1 (en) 2021-09-10 2023-03-16 Longeveron Inc. Treatment of aging frailty comprising administering bone marriw derived mesenchymal stem cells
KR102762783B1 (ko) * 2022-01-21 2025-02-05 고현서 심리 프로파일에 따른 행동 습관 제공 방법, 서버, 저장 매체 및 디바이스
WO2025137077A1 (en) 2023-12-19 2025-06-26 Longeveron, Inc. Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells
WO2025199451A2 (en) 2024-03-21 2025-09-25 Longeveron Inc. Mmp-14 potency assay for mesenchymal stem cells

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120244130A1 (en) * 2009-10-06 2012-09-27 National University Corporation Nagoya University Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
WO2013173694A2 (en) * 2012-05-18 2013-11-21 The Cooper Health System A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs
CN105055450A (zh) * 2015-02-13 2015-11-18 中国福利会国际和平妇幼保健院 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用
WO2015184427A1 (en) * 2014-05-30 2015-12-03 International Cell Technologies, Inc. Method of providing cellular based immune enhancement for restoring immunity and preventing age related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
WO2007149548A2 (en) * 2006-06-22 2007-12-27 Medistem Laboratories, Inc. Treatment of erectile dysfunction by stem cell therapy
WO2010021996A1 (en) * 2008-08-18 2010-02-25 Junta De Beneficiencia De Guayaquil Treatment of injuries to the central nervous system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120244130A1 (en) * 2009-10-06 2012-09-27 National University Corporation Nagoya University Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
WO2013173694A2 (en) * 2012-05-18 2013-11-21 The Cooper Health System A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs
WO2015184427A1 (en) * 2014-05-30 2015-12-03 International Cell Technologies, Inc. Method of providing cellular based immune enhancement for restoring immunity and preventing age related diseases
CN105055450A (zh) * 2015-02-13 2015-11-18 中国福利会国际和平妇幼保健院 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRIAN M. MEHLING等: ""Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation"", vol. 5, no. 8, pages 3 *
VAN T. HOANG等: ""Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction : Literature reviews and study design of a clinical trial"", 《FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY》, vol. 10, pages 1 - 18 *

Also Published As

Publication number Publication date
US12496316B2 (en) 2025-12-16
SG11201912209UA (en) 2020-01-30
AU2018288653A1 (en) 2020-01-16
JP2020524179A (ja) 2020-08-13
TW201919664A (zh) 2019-06-01
WO2018236680A1 (en) 2018-12-27
ZA201908451B (en) 2021-05-26
EP3641793A1 (en) 2020-04-29
JP7343123B2 (ja) 2023-09-12
US20200129558A1 (en) 2020-04-30
CA3067354A1 (en) 2018-12-27
IL271395A (en) 2020-01-30
KR20200017516A (ko) 2020-02-18

Similar Documents

Publication Publication Date Title
CN111107858A (zh) 性功能障碍的治疗和性生活质量的改善
JP7680493B2 (ja) 免疫疾患の治療
Lari et al. Macrophage lineage phenotypes and osteoclastogenesis—Complexity in the control by GM-CSF and TGF-β
AU2012262273B2 (en) Treatment of pain using placental stem cells
JP7491964B2 (ja) 細胞性及び体液性免疫を達成するためのヒト間葉系幹細胞を使用する方法
KR102805246B1 (ko) 수명 및 건강수명을 연장시키기 위한 제제
EP3299451B1 (en) Methods of using adipose tissue-derived cells in the treatment of raynaud's phenomenon
KR20180100251A (ko) 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
US20240009233A1 (en) Macrophage Cell Therapy to Treat Orthopedic Injury
JP2015159895A (ja) 脳梗塞治療のための多能性幹細胞
Meng et al. Exposure to an enriched environment promotes the terminal maturation and proliferation of natural killer cells in mice
KR101852358B1 (ko) 골격근 재생 및 증진을 위한 실데나필의 용도
JP6154280B2 (ja) 神経幹細胞又は神経前駆細胞の増殖促進剤
AU2013204930C1 (en) Therapeutics using multiple injections of cells
HK40109512A (zh) 使用人类间充质干细胞以实现细胞免疫及体液免疫的方法
US20160243198A1 (en) Pharmaceutical Composition for Preventing or Treating Osteoporosis Which Comprises Neuropeptide Y as Active Ingredient
KR20260004499A (ko) 인간 중간엽 줄기 세포를 사용하여 대상체에서 비-허혈성 확장형 심근병증을 치료하는 방법
HK1226601B (en) Methods of using adipose tissue-derived cells in the treatment of raynaud’s phenomenon associated with scleroderma
UA72955U (uk) Спосіб лікування розсіяного склерозу

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Delaware

Applicant after: Meishang Life Sciences Co.,Ltd.

Applicant after: D. L. difield

Address before: Florida USA

Applicant before: American life science Co.

Applicant before: D. L. difield

CB02 Change of applicant information
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200505

WD01 Invention patent application deemed withdrawn after publication